Professor Garry Graham

Day RO; Graham GG; Williams KM, 2013, 'Propionic acid derivative drugs (Profens)', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Graham GG; Day RO, 2013, 'Salicylates', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs', in Encyclopedia of Inflammatory Diseases, edn. 6, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Williams KM; Graham GG, 2013, 'Urate-lowering therapy: Uricosurics', in Dalbeth N; Peresa-Ruiz F; Schlesinger N (ed.), Gout, Future Medicine Ltd, pp. 174 - 188, http://dx.doi.org/10.2217/ebo.13.104

Graham GG, 2005, 'Medicinal chemistry of the disease modifing anti-rheumatic drugs.', in Day RO; Furst DE; van Riel PL; Bresnihan B (ed.), Antirheumatic Therapy: Actions and Outcomes, edn. Original, Birkhauser Verlag, Basel, pp. 1 - 25

Bachmeier CJ; Brooks PM; Day RO; Graham GG; Littlejohn GO; Morand E; Pile K; Williams KM, 2005, 'Disease-modifying anti-rheumatic drugs (DMARD)', in Nijkamp FJ; Parnham MJ (ed.), Principles of Immunopharmacology (2nd Ed), edn. 2nd, Birkhauser Verlag, Basel, pp. 511 - 544

Day RO; Quinn DI; March LM; Graham GG; Williams KM, 2000, 'Rheumatoid arthritis. New Frontiers in pathogenesis and treatment', in NSAIDs and analgesics, edn. Original, Oxford University Press, Oxford, England, pp. 307 - 328

Brady S; Day RO; Graham GG, 1999, 'Are Intra-Articular steroids as effective?', in Challenges in Rheumatoid Arthritis, edn. Original, Blackwell Science, Oxford, UK, pp. 174 - 189

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1999, 'Disease-modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 379 - 403

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1998, 'Disease Modifying antirheumatic drugs', in Textbook of Immunopharmacology, edn. 3, Burkhauser, Basel, Switzerland, pp. 183 - 190, http://dx.doi.org/10.1097/00002281-199705000-00003

Graham GG; Milligan MK; Day RO; Williams KM; Ziegler JB, 1998, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in Rainsford KD; Powanda MC (ed.), Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht, pp. 77 - 92, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000081416000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Graham GG; Milligan MK; Day RO; Williams KM; Zeig , 1997, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in In: `Safety and efficacy of non-prescription (OTC) analgesics, edn. Original, Kluwer Academic Publishers, Great Britain, pp. 77 - 92

Shingde RV; Graham GG; Reuter SE; Carland JE; Day RO; Stocker SL, 2019, 'Comparison of the Area under the Curve for Vancomycin Estimated Using Compartmental and Noncompartmental Methods in Adult Patients with Normal Renal Function', Therapeutic Drug Monitoring, vol. 41, pp. 726 - 731, http://dx.doi.org/10.1097/FTD.0000000000000690

Abdel Shaheed C; Carland JE; Graham GG; Stocker SL; Smith G; Hicks M; Williams KM; Furlong T; Macdonald P; Greenfield JR; Smith FC; Chowdhury G; Day RO, 2019, 'Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis', British Journal of Clinical Pharmacology, vol. 85, pp. 2772 - 2783, http://dx.doi.org/10.1111/bcp.14107

Kamel B; Williams KM; Graham GG; Norris RLG; Stocker SL; Carland JE; Pile KD; Day RO, 2019, 'Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detection', Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 1126-1127, http://dx.doi.org/10.1016/j.jchromb.2019.121764

Tay E; Sotiriou A; Graham GG; Wilhelm K; Snowden L; Day RO, 2019, 'Restarting antidepressant and antipsychotic medication after intentional overdoses: need for evidence-based guidance', THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, vol. 9, http://dx.doi.org/10.1177/2045125319836889

Day RO; Lau W; Stocker SL; Aung E; Coleshill MJ; Schulz M; Bechara J; Carland JE; Graham GG; Williams KM; McLachlan AJ, 2019, 'Management of gout in older people', Journal of Pharmacy Practice and Research, vol. 49, pp. 90 - 97, http://dx.doi.org/10.1002/jppr.1511

Shingde RV; Graham GG; Reuter SE; Carland JE; Day RO; Stocker SL, 2019, 'Comparison of the Area Under the Curve for Vancomycin Estimated Using Compartmental and Noncompartmental Methods in Adult Patients With Normal Renal Function.', Ther Drug Monit, vol. 41, pp. 726 - 731, http://dx.doi.org/10.1097/FTD.0000000000000690

Graham GG, 2018, 'Comment on ‘‘Massive’ metformin overdose’ by Chiew et al.', British Journal of Clinical Pharmacology, vol. 84, pp. 2938 - 2939, http://dx.doi.org/10.1111/bcp.13723

Graham GG; Stocker SL; Kannangara DRW; Day RO, 2018, 'Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout', Current Rheumatology Reports, vol. 20, http://dx.doi.org/10.1007/s11926-018-0760-2

Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2017, 'A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function', European Journal of Clinical Pharmacology, vol. 73, pp. 981 - 990, http://dx.doi.org/10.1007/s00228-017-2251-1

Kamel B; Graham GG; Williams KM; Pile KD; Day RO, 2017, 'Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat', Clinical Pharmacokinetics, vol. 56, pp. 459 - 475, http://dx.doi.org/10.1007/s40262-016-0466-4

Day RO; Kannangara DRW; Stocker SL; Carland JE; Williams KM; Graham GG, 2017, 'Allopurinol: insights from studies of dose–response relationships', Expert Opinion on Drug Metabolism and Toxicology, vol. 13, pp. 449 - 462, http://dx.doi.org/10.1080/17425255.2017.1269745

Kannangara DRW; Graham GG; Wright DFB; Stocker SL; Portek I; Pile KD; Barclay ML; Williams KM; Stamp LK; Day RO, 2017, 'Individualising the dose of allopurinol in patients with gout', British Journal of Clinical Pharmacology, vol. 83, pp. 2015 - 2026, http://dx.doi.org/10.1111/bcp.13307

Moon J; Kumar SS; Graham GG; Baysari MT; Williams KM; Chen W; Viardot A; Greenfield JR; Day RO, 2016, 'Trends in metformin utilisation and dose appropriateness in Australia', European Journal of Clinical Pharmacology, vol. 72, pp. 1489 - 1496, http://dx.doi.org/10.1007/s00228-016-2117-y

Smith FC; Kumar SS; Furlong TJ; Gangaram SV; Greenfield JR; Stocker SL; Graham GG; Williams KM; Day RO, 2016, 'Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration', American Journal of Kidney Diseases, vol. 68, pp. 990 - 992, http://dx.doi.org/10.1053/j.ajkd.2016.08.017

Mahler SM; Wardiana A; Jones ML; de Bakker CJ; Graham GG; Howard CB, 2016, 'Biosimilars approved for treatment of inflammatory rheumatological diseases', International Journal of Rheumatic Diseases, vol. 19, pp. 1043 - 1048, http://dx.doi.org/10.1111/1756-185X.13037

Kannangara DRW; Graham GG; Williams KM; Day RO, 2016, 'Effect of xanthine oxidase inhibitors on the renal clearance of uric acid and creatinine', Clinical Rheumatology, vol. 35, pp. 2375 - 2376, http://dx.doi.org/10.1007/s10067-015-3165-x

Kannangara DRW; Phipps-Green AJ; Dalbeth N; Stamp LK; Williams KM; Graham GG; Day RO; Merriman TR, 2016, 'Hyperuricaemia: Contributions of urate transporter ABCG2 and the fractional renal clearance of urate', Annals of the Rheumatic Diseases, vol. 75, pp. 1363 - 1366, http://dx.doi.org/10.1136/annrheumdis-2015-208111

Day RO; Kamel B; Kannangara DRW; Williams KM; Graham GG, 2016, 'Xanthine oxidoreductase and its inhibitors: Relevance for gout', Clinical Science, vol. 130, pp. 2167 - 2180, http://dx.doi.org/10.1042/CS20160010

Chung WH; Chang WC; Stocker SL; Juo CG; Graham GG; Lee MHH; Williams KM; Tian YC; Juan KC; Wu YJJ; Yang CH; Chang CJ; Lin YJ; Day RO; Hung SI, 2015, 'Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: The impact of renal insufficiency, high plasma levels of oxypurinol and granulysin', Annals of the Rheumatic Diseases, vol. 74, pp. 2157 - 2164, http://dx.doi.org/10.1136/annrheumdis-2014-205577

Duong JK; Kumar SS; Furlong TJ; Kirkpatrick CM; Graham GG; Greenfield JR; Williams KM; Day RO, 2015, 'The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitus', British Journal of Clinical Pharmacology, vol. 79, pp. 617 - 623, http://dx.doi.org/10.1111/bcp.12525

Ghosh D; Williams KM; Graham GG; Nair P; Buscher H; Day RO, 2014, 'Multiple episodes of aspirin overdose in an individual patient: A case report', Journal of Medical Case Reports, vol. 8, pp. 1 - 5, http://dx.doi.org/10.1186/1752-1947-8-374

Kannangara DRW; Graham GG; Williams KM; Day RO, 2014, 'Hypouricemic effects of prednisone and allopurinol: An uneven playing field?', Canadian Journal of Cardiology, vol. 30, pp. 376.e1, http://dx.doi.org/10.1016/j.cjca.2013.04.015

Kannangara DRW; Ramasamy SN; Ray JE; Jones G; Graham GG; Williams KM; Day RO, 2013, 'An audit of a therapeutic drug monitoring service for allopurinol therapy', Therapeutic Drug Monitoring, vol. 35, pp. 863 - 866, http://dx.doi.org/10.1097/FTD.0b013e318299920a

Day RO; Graham GG, 2013, 'Republished research: Non-steroidal anti-inflammatory drugs (NSAIDs)', British Journal of Sports Medicine, vol. 47, pp. 1127, http://dx.doi.org/10.1136/bjsports-2013-f3195rep

Ramasamy SN; Korb-Wells CS; Kannangara DRW; Smith MWH; Wang N; Roberts DM; Graham GG; Williams KM; Day RO, 2013, 'Allopurinol hypersensitivity: A systematic review of all published cases, 1950-2012', Drug Safety, vol. 36, pp. 953 - 980, http://dx.doi.org/10.1007/s40264-013-0084-0

Day R; Lee H; Graham G; Williams K, 2013, 'Benzbromarone: Availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt on benzbromarone)', New Zealand Medical Journal, vol. 126, pp. 124 - 126

Wong C; Kumar SS; Graham GG; Begg EJ; Chin P; Brett J; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Comparing dose prediction software used to manage gentamicin dosing', Internal Medicine Journal, vol. 43, pp. 519 - 525, http://dx.doi.org/10.1111/imj.12067

Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs (NSAIDs)', BMJ, vol. 346, pp. Article No. f3195, http://dx.doi.org/10.1136/bmj.f3195

Graham GG; Davies MJ; Day RO; Mohamudally A; Scott KF, 2013, 'The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.', Inflammopharmacology, vol. 21, pp. 201 - 232, http://dx.doi.org/10.1007/s10787-013-0172-x

Brett J; Chong O; Graham GG; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Antifungal Use and Therapeutic Monitoring of Plasma Concentrations of Itraconazole in Heart and Lung Transplantation Patients.', Therapeutic Drug Monitoring, vol. 35, pp. 133 - 136, http://dx.doi.org/10.1097/FTD.0b013e318275fe69

Kannangara DRW; Graham GG; Williams KM; Day RO, 2013, 'Hypouricemic Effects of Prednisone and Allopurinol: An Uneven Playing Field?', Canadian Journal of Cardiology, http://dx.doi.org/10.1016/j.cjca.2013.04.015

Duong JK; Kumar SS; Carl m kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR; Williams KM; Day RO, 2013, 'Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes: Simulation of doses according to renal function', Clinical Pharmacokinetics, vol. 52, pp. 373 - 384, http://dx.doi.org/10.1007/s40262-013-0046-9

Graham GG; Kannangara DRW; Stocker S; Portek I; Pile K; Indraratna PL; Datta I; Williams KM; Day RO, 2013, 'Understanding the dose-response relationship of allopurinol: predicting the optimal dosage', British Journal of Clinical Pharmacology, vol. 76, pp. 932 - 938, http://dx.doi.org/10.1111/bcp.12126

Day RO; Duong JK; Furlong TJ; Roberts DM; Graham GG; Greenfield JR; Williams KM, 2013, 'The role of metformin in metformin-associated lactic acidosis (MALA): Case series and formulation of a model of pathogenesis', Drug Safety, vol. 36, pp. 733 - 746, http://dx.doi.org/10.1007/s40264-013-0038-6

Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'Metformin therapy in patients with chronic kidney disease', Diabetes Obesity and Metabolism, vol. 14, pp. 963 - 965, http://dx.doi.org/10.1111/j.1463-1326.2012.01617.x

Lee M-H; Stocker S; Anderson JM; Phillips EJ; Nolan DL; Williams KM; Graham GG; Sullivan JR; Day RO, 2012, 'Initiating allopurinol therapy: Do we need to know the patient's human leucocyte antigen status?', Internal Medicine Journal, vol. 42, pp. 411 - 416, http://dx.doi.org/10.1111/j.1445-5994.2011.02567.x

Kannangara DRW; Ramasamy SN; Indraratna P; Stocker S; Graham GG; Jones G; Portek I; Williams KM; Day RO, 2012, 'Fractional clearance of urate: Validation of measurement in spot urine samples in healthy subjects and gouty patients', Arthritis Research and Therapy, vol. 14, pp. R189 - R197, http://dx.doi.org/10.1186/ar4020

Kannangara D; Roberts DM; Furlong TJ; Graham GG; Williams K; Day RO, 2012, 'Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease', British Journal of Clinical Pharmacology, vol. 73, pp. 828 - 829, http://dx.doi.org/10.1111/j.1365-2125.2011.04147.x

Stocker S; Mclachlan AJ; Savic RM; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'The pharmacokinetics of oxypurinol in people with gout', British Journal of Clinical Pharacology, vol. 74, pp. 477 - 489, http://dx.doi.org/10.1111/j.1365-2125.2012.04207.x

Ramasamy S; Kannangara D; Indraratna P; Stocker S; Jones G; Graham G; Williams K; Day R, 2011, 'ESTABLISHING THE USEFULNESS OF A SPOT URINE COLLECTION IN CALCULATING THE FRACTIONAL RENAL CLEARANCE OF URATE (FCU)', INTERNAL MEDICINE JOURNAL, vol. 41, pp. 31 - 31, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kannangara D; Datta I; Indraratna P; Stocker S; Portek I; Graham G; Williams K; Day R, 2011, 'INDIVIDUALISING ALLOPURINOL THERAPY IN GOUT', INTERNAL MEDICINE JOURNAL, vol. 41, pp. 30 - 30, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Greenfield JR; Graham GG; Day RO, 2011, 'The Use of Metformin in Diabetic Patients with Renal Impairment', Geriatric Medicine in General Practice, vol. 8, pp. 26 - 29, http://search.informit.com.au/documentSummary;dn=109054076198131;res=IELHEA

Graham GG; Punt J; Manit A; Day RO; Doogue MP; Duong JK; Furlong TJ; Greenfield JR; Greenup L; Carl m kirkpatrick CM; Ray J; Timmins P; Williams KM, 2011, 'Clinical pharmacokinetics of metforim', Clinical Pharmacokinetics, vol. 50, pp. 81 - 98, http://dx.doi.org/10.2165/11534750-000000000-00000

Bryant KJ; Bidgood MJ; Lei P; Taberner ML; Salom C; Kumar V; Lee LK; Church W; Courtenay BG; Smart BP; Gelb M; Cahill MA; Graham GG; McNeil HP; Scott KF, 2011, 'A bifunctional role for group IIA secreted phospolipase A2 in human rheumatoid fibroblast-like synoviocyte arachidonic acid metabolism', The Journal of Biological Chemistry, vol. 286, pp. 2492 - 2503, http://dx.doi.org/10.1074/jbc.M110.123927

Ng DY; Stocker SL; Graham GG; Williams KM; Day RO, 2011, 'Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers', European Journal of Clinical Pharmacology, vol. 67, pp. 709 - 713, http://dx.doi.org/10.1007/s00228-010-0963-6

Ray J; Campbell G; Richardson T; Erickson G; Carr V; Rofe P; Tassaneeyakul W; Graham G, 2010, 'OPTIMISING CLOZAPINE THERAPY: A NEW MODEL OF CLOZAPINE THERAPEUTIC DRUG MONITORING', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, vol. 44, pp. A26 - A26, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282954700069&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Graham GG; Day RO; Graudins A; Mohamudally A, 2010, 'Erratum: FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): Are they reasonable? (Inflammopharmacol DOI: 10.1007/s10787-010-0036-6)', Inflammopharmacology, vol. 18, pp. 57, http://dx.doi.org/10.1007/s10787-010-0039-3

Koelsch M; Mallak R; Graham GG; Kajer T; Milligan MK; Nguyen L; Newsham DW; Keh JS; Kettle AJ; Scott KF; Ziegler JB; Pattison DI; Fu S; Hawkins C; Rees M; Davies MJ, 2010, 'Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations', Biochemical Pharmacology, vol. 79, pp. 1156 - 1164, http://dx.doi.org/10.1016/j.bcp.2009.11.024

Indraratna P; Williams KM; Graham GG; Day RO, 2009, 'Hyperuricemia, Cardiovascular Disease and the Metabolic Syndrome', The Journal of Rheumatology, vol. 36, pp. 2842 - 2843, http://dx.doi.org/10.3899/jrheum.090500

Lee M; Graham GG; Williams KM; Day RO, 2008, 'A benefit-risk assessment of benzbromarone in the treatment of gout - was its withdrawal from the market in the best interest of patients?', Drug Safety, vol. 31, pp. 643 - 665, http://dx.doi.org/10.2165/00002018-200831080-00002

Graham GG; Whitehouse M; Bushell G, 2008, 'Aurocyanide, dicyano-aurate(I), a pharmacologically active metabolite of medicinal gold complexes', Inflammopharmacology, vol. 16, pp. 126 - 132, http://dx.doi.org/10.1007/s10787-007-0020-y

Chung YW; Lu CY; Graham GG; Mant A; Day RO, 2008, 'Utilization of allopurinol in the Australian community', Internal Medicine Journal, vol. 38, pp. 388 - 395, http://dx.doi.org/10.1111/j.1445-5994.2008.01641.x

Chung Y; Stocker S; Graham GG; Day RO, 2008, 'Optimizing therapy with allopurinol: Factors limiting hypouricemic efficacy', American Journal of the Medical Sciences, vol. 335, pp. 219 - 226, http://dx.doi.org/10.1097/MAJ.0b013e31815acb10

Stocker S; Williams KM; Mclachlan AJ; Graham GG; Day RO, 2008, 'Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects', Clinical Pharmacokinetics, vol. 47, pp. 111 - 118, http://dx.doi.org/10.2165/00003088-200847020-00004

Nevalainen TJ; Graham GG; Scott KF, 2008, 'Antibacterial actions of secreted phospholipases A(2). Review', Biochimica et Biophysica ACTA - Molecular and Cell Biology of Lipids, vol. 1781, pp. 1 - 9, http://dx.doi.org/10.1016/j.bbalip.2007.12.001

McLachlan AJ; Day RO; Williams KM; Graham GG, 2008, 'Maximising gout therapy', Australian Journal of Pharmacy, vol. 89, pp. 86 - 88

Graham GG; Day RO, 2007, 'Expert comment [6]', Australian Prescriber, vol. 30, pp. 61 - 62

Day RO; Graham G; Williams K, 2007, 'Fenofibratewarfarin interaction [1]', Australian Prescriber, vol. 30, pp. 32, http://dx.doi.org/10.18773/austprescr.2007.014

Day RO; Graham GG; Hicks M; Mclachlan AJ; Stocker S; Williams KM, 2007, 'Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol', Clinical Pharmacokinetics, vol. 46, pp. 623 - 644, http://dx.doi.org/10.2165/00003088-200746080-00001

Dong Q; Patel M; Scott KF; Graham GG; Russell PJ; Sved P, 2006, 'Oncogenic action of phospholipase A2 in prostate cancer', Cancer Letters, vol. 240, pp. 9 - 16, http://dx.doi.org/10.1016/j.canlet.2005.08.012

Scott KF; Lei P-W; Lee LK; Bidgood MJ; Taberner M; Salom C; Courtenay BG; Bryant KJ; Church WB; Graham GG; McNeill HP, 2005, 'Regulation of intracellular prostaglandin biosynthetic pathways by "outside-in" secreted phospholipase A(2)-dependent signalling in fibroblast-like synoviocytes', INFLAMMATION RESEARCH, vol. 54, pp. S182 - S182, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600313&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Byrne A; Graham G; Hallinan R; Murnion B; Hulse GK; Arnold-Reed DE; Wodak A; Graham R; Hulse GK, 2005, 'Naltrexone implants as treatment for heroin dependence: Part I (multiple letters)', Addiction Biology, vol. 10, pp. 201, http://dx.doi.org/10.1080/13556210500155789

Graham GG; Day RO, 2005, 'Tolerability of paracetamol', Drug Safety, vol. 28, pp. 227 - 240, http://dx.doi.org/10.2165/00002018-200528030-00004

Day RO; Graham GG, 2005, 'Paracetamol should be first-line therapy in osteoarthritis', Medical Journal of Australia, vol. 182, pp. 198 - 199

Graham GG; Scott KF, 2005, 'Mechanism of action of paracetamol', American Journal of Therapeutics, vol. 12, pp. 46 - 55, http://dx.doi.org/10.1097/00045391-200501000-00008

Day RO; Graham GG, 2004, 'The vascular effects of COX-2 selective inhibitors', Australian Prescriber, vol. 27, pp. 142 - 145, http://dx.doi.org/10.18773/austprescr.2004.119

Sved P; Scott KF; McLeod D; King NJ; Singh J; Tsatralis T; Nikolov B; Boulas J; Nallan L; Gelb M; Sajinovic M; Graham GG; Russell PJ; Dong Q, 2004, 'Oncogenic action of secreted phospholipase A(2) in prostate cancer', Cancer research, vol. 64, pp. 6934 - 6940, http://dx.doi.org/10.1158/0008-5472.CAN-03-3018

Lee EJ; Williams KM; Day RO; Graham GG; Champion D, 2004, 'Stereoselective disposition of ibuprofen enantiomers in man (Reprintedfrom Br J Clin Pharmacol, vol 19, pg 669-674, 1985)', British Journal of Clinical Pharmacology, vol. 58, pp. S759 - S764, http://dx.doi.org/10.1111/j.1365-2125.2004.02288.x

Graham GG; Scott KF; Day RO, 2003, 'Tolerability of Paracetamol', Drugs, vol. 63, pp. 43 - 46, http://dx.doi.org/10.2165/00003495-200363992-00007

Graham GG; Scott KF; Day RO, 2003, 'Tolerability of paracetamol', DRUGS, vol. 63, pp. 43 - 46, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186278900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Scott KF; Graham GG; Bryant KJ, 2003, 'Secreted phospholipase A2 enzymes as therapeutic targets', Expert Opinion on Therapeutic Targets, vol. 7, pp. 427 - 440

Graham GG; Scott KF, 2003, 'Mechanism of action of paracetamol and related analgesics', Inflammopharmacology, vol. 11, pp. 401 - 413, http://dx.doi.org/10.1163/156856003322699573

Scott KF; Graham GG; Bryant KJ, 2003, 'Secreted Phospholipase AS enzymes as therapeutic targets', Expert Opinion on Therapeutic Targets, vol. 7, pp. 427 - 447, http://dx.doi.org/10.1517/14728222.7.3.427

Graham GG; Kettle AJ, 2002, 'Formation of aurocyanide by lactoperoxidase and its inhibition by paracetamol (acetaminophen)', FREE RADICAL BIOLOGY AND MEDICINE, vol. 33, pp. S178 - S178, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000177096300470&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Graham GG; Graham RM; Day RO, 2002, 'Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol)', Current Pharmaceutical Design, vol. 8, pp. 1063 - 1075, http://dx.doi.org/10.2174/1381612023394917

Graham GG; Robins SA; Bryant KJ; Scott KF, 2001, 'Inhibition of prostaglandin synthesis in intact cells by paracetamol (acetaminophen)', Inflammopharmacology, vol. 9, pp. 131 - 142, http://dx.doi.org/10.1163/156856001300248407

Begg EJ; Robson RA; Saunders DA; Graham GG; Buttimore RC; Neill AM; Town GI, 2000, 'The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing', British Journal of Clinical Pharmacology, pp. 32 - 38

Morlet N; Graham GG; Gatus BJ; Mclachlan AJ; Salonikas C; Naidoo D; Goldberg I; Lam CK, 2000, 'The pharmacokinetics of ciprofloxacin in the human eye: A clinical study and population pharmacokinetic analysis', Antimicrobial Agents and Chemotherapy, pp. 1674 - 1679

Day RO; Graham GG; Whelton A, 2000, 'The position of paracetamol in the world of analgesics.', American Journal of Therapeutics, pp. 51 - 54

Morlet N; Graham GG; Gatus BJ; Mclachlan AJ; Salonikas C; Naidoo D; Goldberg I; Lam CK, 2000, 'Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis', Antimicrobial Agents and Chemotherapy, vol. 44, pp. 1674 - 1679, http://dx.doi.org/10.1128/AAC.44.6.1674-1679.2000

Day RO; Graham GG; Whelton A, 2000, 'The position of paracetamol in the world of analgesics', American Journal of Therapeutics, vol. 7, pp. 51 - 54, http://dx.doi.org/10.1097/00045391-200007020-00002

Day RO; Mclachlan AJ; Graham GG; Williams KM, 1999, 'Pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid', Clinical Pharmacokinetics, vol. 36, pp. 191 - 210, http://dx.doi.org/10.2165/00003088-199936030-00002

Erb K; Brugger R; Williams KM; Geisslinger G, 1999, 'Stereoselective disposition of tiaprofenic acid enantiomers in rats', Chirality, vol. 11, pp. 103 - 108

Graham GG; Day RO; Milligan MK; Ziegler JB; Kettle AJ, 1999, 'Current Concepts of the actions of paracetamol (acetaminophen) and NSAIDS', Inflammopharmacology, vol. 7, pp. 255 - 263, http://dx.doi.org/10.1007/s10787-999-0008-x

Graham GG; Kettle AJ, 1998, 'The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase.', Biochem Pharmacol, vol. 56, pp. 307 - 312, http://dx.doi.org/10.1016/s0006-2952(98)00031-8

Bollisetty S; Gupta JM; Graham GG; Salonikas C; Naidoo D, 1998, 'Vitamin K in preterm breastmilk with maternal supplementation', ACTA Paediatrica, pp. 960 - 962

Bolisetty S; Gupta JM; Graham GG; Salonikas C; Naidoo D, 1998, 'Vitamin K in pre-term breastmilk with maternal supplementation', ACTA Paediatrica, vol. 87, pp. 960 - 962, http://dx.doi.org/10.1080/080352598750031626

Warwick NR; Graham GG; Torda TA, 1998, 'Pharmacokinetic analysis of the effect of vecuronium in surgical patients: pharmacokinetic and pharmacodynamic modeling without plasma concentrations.', Anesthesiology, vol. 88, pp. 874 - 884, http://dx.doi.org/10.1097/00000542-199804000-00005

Graham GG; Kettle AJ, 1998, 'The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes', Biochemical Pharmacology, vol. 56, pp. 307 - 312, http://dx.doi.org/10.1016/S0006-2952(98)00031-8

Warwick NR; Graham GG; Torda TA, 1998, 'Pharmacokinetic analysis of the effect of vecuronium in surgical patients', Anesthesiology, vol. 88, pp. 874 - 884, http://dx.doi.org/10.1097/00000542-199804000-00005

Quane PA; Graham GG; Ziegler JB, 1998, 'Pharmacology of Benzydamine', Inflammopharmacology, vol. 6, pp. 95 - 107, http://dx.doi.org/10.1007/s10787-998-0026-0

Torda TA; Graham GG; Warwick NR, 1997, 'A normal distribution model fo r the pharmacodynamics of nondepolarising neuromuscular blockers', Anaesthesia and Intensive Care, pp. 279 - 281

Torda TA; Graham GG; Warwick NR; Donohue PM, 1997, 'Pharmacokinetics and pharmacodynamics of suxamethonium', Anaesthesia and Intensive Care, pp. 272 - 278

Saunders DA; Evan J; Kirkpatrick CM; Yeo J; Graham GG; Bailey RR, 1997, 'Measurement of total phospholipids in urine of patients treated with Gentamicin', British Journal of Clinical Pharmacology, vol. 43, pp. 435 - 440, http://dx.doi.org/10.1046/j.1365-2125.1997.00568.x

Torda TA; Graham GG; Warwick NR, 1997, 'A normal distribution model for the pharmacodynamics of nondepolarising neuromuscular blockers,', Anaesthesia and Intensive Care, vol. 25, pp. 279 - 281

Torda TA; Graham GG; Warwick NR; Donohue PM, 1997, 'Pharmacokinetics and pharmacodynamics of Suxamethonium,', Anaesthesia and Intensive Care, vol. 25, pp. 272 - 278

Whitehouse MW; Graham GG, 1996, 'Is local biotransformation the key to understanding the pharmacological activity of salicylates and gold drugs?', Inflammation Research, vol. 45, pp. 579 - 582, http://dx.doi.org/10.1007/BF02312038

Morlet N; Young S; Naidoo D; Graham GG; Coroneo MT, 1996, 'High dose intravitreal gonciclovir injection provides a prolonged therapeutic intracular concentration', British Journal of Ophthalmology, pp. 214 - 216

Graham GG; Day RO; Wong H; Mclachlan AJ; Bergendal L; Miners JO; Birkett DJ, 1996, 'Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects', British Journal of Clinical Pharmacology, vol. 41, pp. 299 - 304

Morlet N; Young S; Naidoo D; Graham GG; Coroneo MT, 1996, 'High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration', British Journal of Ophthalmology, vol. 80, pp. 214 - 216, http://dx.doi.org/10.1136/bjo.80.3.214

Graham GG; Gordon D; Sadler PJ, 1996, 'Reactions of the antiarthritic drug aurothiomalate with phenylmercury(11) compounds: NMR studies,', Metal - Based Drugs, vol. 3, pp. 269 - 276, http://dx.doi.org/10.1155/MBD.1996.269

MORLET N; STAYT J; NAIDOO D; GRAHAM G; CROUCH R; CORONEO MT, 1995, 'VIROCIDAL TREATMENT OF CMV RETINITIS', INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 36, pp. S181 - S181, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QM91500858&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

YOUNG SH; MORLET N; GRAHAM G; NAIDOO D; CORONEO MT, 1995, 'IMPROVED TREATMENT OF CMV RETINITIS USING HIGH-DOSE INTRAVITREAL GANCICLOVIR WITH PROLONGED THERAPEUTIC INTRAOCULAR CONCENTRATIONS', INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 36, pp. S323 - S323, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QM91501503&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Warwick NR; Graham GG; Torda TA, 1995, 'Pharmacokinetic analysis of the time course of effect of atracurium', Clinical Pharmacology and Therapeutics, pp. 390 - 397

Johnson AG; Quinn DE; Day RO, 1995, 'Non-steroidal anti-inflammatory drugs', Medical Journal of Australia, vol. 163, pp. 155 - 158, http://dx.doi.org/10.1136/bmj.f3195

Warwick NR; Graham GG; Torda TA, 1995, 'Pharmacokenetic analysis of the time course of effect at atracurium', Clinical Pharmacology and Therapeutics, vol. 57, pp. 390 - 397, http://dx.doi.org/10.1016/0009-9236(95)90207-4

LAU ATS; GRAHAM GG; DAY RO; PERRY MA, 1994, 'EFFECT OF HCL CONCENTRATION ON GASTRIC BLOOD-FLOW IN ACUTE ASPIRIN-INDUCED GASTRIC-ULCERS IN THE CAT', GASTROENTEROLOGY, vol. 106, pp. A123 - A123, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NH90900484&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Torda TA, 1994, 'The Kinetics of Effect of Neuromuscular Blocking Drugs', The Keio Journal of Medicine, vol. 43, pp. 27 - 30, http://dx.doi.org/10.2302/kjm.43.27

Palasanthiran P; Robertson P; Ziegler JB; Graham GG, 1994, 'Decay of transplacental human immunodeficiency virus type 1 antibodies in neonates and infants', Journal of Infectious Diseases, vol. 170, pp. 1593 - 1596, http://dx.doi.org/10.1093/infdis/170.6.1593

Day RO; Birkett DJ; Hicks M; Miners JO; Graham GG; Brooks PM, 1994, 'New Uses for Allopurinol', Drugs, vol. 48, pp. 339 - 344, http://dx.doi.org/10.2165/00003495-199448030-00002

Seideman P; Lohrer F; Graham G; Duncan M; Williams K; Day R, 1994, 'The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid.', British Journal of Clinical Pharmacology, vol. 38, pp. 221 - 227, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04345.x

MISHRA Y; TORDA T; RAMZAN I; GRAHAM G, 1994, 'In‐vitro Interaction between H2 Antagonists and Vecuronium', Journal of Pharmacy and Pharmacology, vol. 46, pp. 205 - 208, http://dx.doi.org/10.1111/j.2042-7158.1994.tb03779.x

Graham GG; Champion GD; Ziegler JB, 1994, 'The cellular metabolism and effects of gold complexes.', Met Based Drugs, vol. 1, pp. 395 - 404, http://dx.doi.org/10.1155/MBD.1994.395

TORDA TA; GRAHAM GG; WARWICK NR, 1993, 'GAUSSIAN MODEL OF THE PHARMACODYNAMICS OF THE NEUROMUSCULAR-JUNCTION', ANESTHESIOLOGY, vol. 79, pp. A922 - A922, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993LY10800921&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Meyer-Carrive I; Graham GG; Ghosh P, 1993, 'Pharmacokinetics of tiaprofenic acid in normal rabbits and rabbits subjected to joint immobilisation', Agents and Actions, vol. 39, pp. 59 - 68, http://dx.doi.org/10.1007/BF01975715

Davis AL; Begg EJ; Kennedy MC; Graham GG, 1993, 'Application of a simplified method to determine bioavailability of an oral dose of phenytoin', Journal of Pharmacokinetics and Biopharmaceutics, vol. 21, pp. 195 - 208, http://dx.doi.org/10.1007/BF01059770

Day RO; Brooks PM; Williams KM; Graham GG, 1993, 'Meeting report: Third world conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992', Agents and Actions, vol. 38

Day RO; Brooks PM; Williams KM; Graham GG, 1993, 'Third World conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992.', Agents and actions, vol. 38, http://dx.doi.org/10.1007/bf01976204

Brooks PM; Day RO; Graham GG; Williams KM, 1993, 'Preface', Agents and Actions, vol. 44

Rudkowski R; Ziegler JB; Graham GG; Joulianos G, 1992, 'Gold complexes and activation of human polymorphonuclear leukocytes. Dissociation of changes in membrane potential and oxidative burst', Biochemical Pharmacology, vol. 44, pp. 1091 - 1098, http://dx.doi.org/10.1016/0006-2952(92)90372-P

LAU ATS; GRAHAM GG; DAY RO; PERRY MA, 1992, 'EFFECT OF ASPIRIN ON ULCER SITE BLOOD-FLOW IN CAT STOMACHS', AMERICAN JOURNAL OF PHYSIOLOGY, vol. 263, pp. G155 - G160, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992JJ95800072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lau ATS; Graham GG; Day RO; Perry MA, 1992, 'Effect of aspirin on ulcer site blood flow in cat stomachs', American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 263, http://dx.doi.org/10.1152/ajpgi.1992.263.2.g155

Lau AT; Graham GG; Day RO; Perry MA, 1992, 'Effect of aspirin on ulcer site blood flow in cat stomachs.', Am J Physiol, vol. 263, pp. G155 - G160, http://dx.doi.org/10.1152/ajpgi.1992.263.2.G155

Rudkowski R; Ziegler JB; Graham GG; Champion GD, 1991, 'Auranofin inhibits the activation pathways of polymorphonuclear leukocytes at multiple sites', Biochemical Pharmacology, vol. 41, pp. 1921 - 1929, http://dx.doi.org/10.1016/0006-2952(91)90132-O

Graham GG; Champion GD; Ziegler JB, 1991, 'The antirheumatic gold complexes: Considerations of chemical form in studies on their mechanism of action', Inflammopharmacology, vol. 1, pp. 99 - 102, http://dx.doi.org/10.1007/BF02735391

Carmody JJ; Graham GG; Ruigrok MA, 1991, 'STRESS IN MICE INCREASES INTRINSIC PENTOBARBITONE SENSITIVITY BY A PREDOMINANTLY PHARMACODYNAMIC MECHANISM', Clinical and Experimental Pharmacology and Physiology, vol. 18, pp. 703 - 710, http://dx.doi.org/10.1111/j.1440-1681.1991.tb01384.x

Rudkowski R; Graham GG; Ziegler JB; Champion GD, 1991, 'The effect of aurothiomalate on the oxidative burst of polymorphonuclear leukocytes varies with the quantity of drug in myocrisin ampoules', Journal of Rheumatology, vol. 18, pp. 666 - 671

Graham GG; Torda TA; Tsui D, 1990, 'A simplified analysis of the kinetics of effect of muscle relaxants', European Journal of Pharmacology, vol. 183, pp. 1594 - 1595, http://dx.doi.org/10.1016/0014-2999(90)94760-U

Rudkowski R; Graham GG; Champion GD; Ziegler JB, 1990, 'The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes-I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytes', Biochemical Pharmacology, vol. 39, pp. 1687 - 1695, http://dx.doi.org/10.1016/0006-2952(90)90112-X

Graham GG; Dale MM, 1990, 'The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes-II. Evidence for the formation and biological activity of aurocyanide', Biochemical Pharmacology, vol. 39, pp. 1697 - 1702, http://dx.doi.org/10.1016/0006-2952(90)90113-Y

Graham GG; Tsui D; Torda TA, 1990, 'A simplified approach to the effect kinetics of atracurium', British Journal of Anaesthesia, vol. 64, pp. 28 - 32, http://dx.doi.org/10.1093/bja/64.1.28

Torda TA; Graham GG; Tsui D, 1990, 'Neuromuscular sensitivity to atracurium in humans', Anaesthesia and Intensive Care, vol. 18, pp. 62 - 68, http://dx.doi.org/10.1177/0310057x9001800111

Knihinicki RD; Day RO; Graham GG; Williams KM, 1990, 'Stereoselective disposition of ibuprofen and flurbiprofen in rats', Chirality, vol. 2, pp. 134 - 140, http://dx.doi.org/10.1002/chir.530020303

Champion GD; Graham GG; Ziegler JB, 1990, 'The gold complexes', Bailliere's Clinical Rheumatology, vol. 4, pp. 491 - 534, http://dx.doi.org/10.1016/S0950-3579(05)80005-6

Day R; Graham G; Bieri D; Brown M; Cairns D; Harris G; Hounsell J; Platt‐ Hepworth S; Reeve R; Sambrook P; et al , 1989, 'Concentration‐response relationships for salicylate‐induced ototoxicity in normal volunteers.', British Journal of Clinical Pharmacology, vol. 28, pp. 695 - 702, http://dx.doi.org/10.1111/j.1365-2125.1989.tb03562.x

RUDKOWSKI R; JACOB M; GRAHAM GG; CHAMPION GD, 1988, 'IS AUROTHIOMALATE AN ACTIVATOR OR INHIBITOR OF HUMAN-NEUTROPHILS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, vol. 18, pp. 521 - 521, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N917000676&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Day RO; Graham GG; Williams KM, 1988, 'Pharmacokinetics of non-steroidal anti-inflammatory drugs', Bailliere's Clinical Rheumatology, vol. 2, pp. 363 - 393, http://dx.doi.org/10.1016/S0950-3579(88)80019-0

Graham GG, 1988, 'Kinetics of non-steroidal anti-inflammatory drugs in synovial fluid.', Agents and actions. Supplements, vol. 24, pp. 66 - 75, http://dx.doi.org/10.1007/978-3-0348-9160-8_6

Day RO; Graham GG; Willia KM; Brooks PM, 1988, 'Variability in Response to NSAIDs: Fact or Fiction?', Drugs, vol. 36, pp. 643 - 651, http://dx.doi.org/10.2165/00003495-198836060-00001

Day RO; Williams KM; Graham GG; Lee EJ; Knihinicki RD; Champion GD, 1988, 'Stereoselective disposition of ibuprofen enantiomers in synovial fluid', Clinical Pharmacology and Therapeutics, vol. 43, pp. 480 - 487, http://dx.doi.org/10.1038/clpt.1988.62

Day R; Miners J; Birkett D; Graham G; Whitehead A, 1988, 'Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.', British Journal of Clinical Pharmacology, vol. 26, pp. 429 - 434, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03402.x

Day R; Harris G; Brown M; Graham G; Champion G, 1988, 'Interaction of salicylate and corticosteroids in man.', British Journal of Clinical Pharmacology, vol. 26, pp. 334 - 337, http://dx.doi.org/10.1111/j.1365-2125.1988.tb05286.x

Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; De Jager J; Sambrook PN, 1988, 'Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis', Journal of Rheumatology, vol. 15, pp. 28 - 34

Rauch K; Ray J; Graham G, 1988, 'Improved high-performance liquid chromatographic method for the determination of quinine in plasma', Journal of Chromatography B: Biomedical Sciences and Applications, vol. 430, pp. 170 - 174, http://dx.doi.org/10.1016/S0378-4347(00)83148-5

Bochner F; Graham GG; Polverino A; Imhoff DM; Tregenza RA; Rolan PE; Cleland LG, 1987, 'Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis', European Journal of Clinical Pharmacology, vol. 32, pp. 153 - 158, http://dx.doi.org/10.1007/BF00542188

RUDKOWSKI R; CHAMPION GD; GRAHAM GG; ZIEGLER JB, 1987, 'THE EFFECTS OF AUROCYANIDE, AUROTHIOMALATE AND AURANOFIN ON THE OXIDATIVE BURST OF POLYMORPHONUCLEAR LEUKOCYTES', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, vol. 17, pp. 117 - 117, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1987G353300027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Graham GG, 1987, 'Pharmacokinetics and metabolism of non-steroidal anti-inflammatory drugs', Medical Journal of Australia, vol. 147, pp. 597 - 602, http://dx.doi.org/10.5694/j.1326-5377.1987.tb133697.x

Tsui D; Graham GG; Torda TA, 1987, 'The pharmacokinetics of atracurium isomers in vitro and in humans.', Anesthesiology, vol. 67, pp. 722 - 728, http://dx.doi.org/10.1097/00000542-198711000-00017

Day RO; Graham GG; Williams KM; David Champion G; de Jager J, 1987, 'Clinical pharmacology of non-steroidal anti-inflammatory drugs', Pharmacology and Therapeutics, vol. 33, pp. 383 - 433, http://dx.doi.org/10.1016/0163-7258(87)90072-6

Graham GG; Morris R; Pybus DA; Torda TA; Woodey R, 1986, 'Relationship of train-of-four ratio to twitch depression during pancuronium-induced neuromuscular blockade', Anesthesiology, vol. 65, pp. 579 - 583, http://dx.doi.org/10.1097/00000542-198612000-00003

Graham GG; Bales JR; Grootveld MC; Sadler PJ, 1985, '¹H, ¹³C NMR, and electronic absorption spectroscopic studies of the interaction of cyanide with aurothiomalate', Journal of Inorganic Biochemistry, vol. 25, pp. 163 - 173, http://dx.doi.org/10.1016/0162-0134(85)80010-6

GRAHAM GG; BALES JR; GROOTVELD MC; SADLER PJ, 1985, 'H-1, C-13 NMR, AND ELECTRONIC ABSORPTION SPECTROSCOPIC STUDIES OF THE INTERACTION OF CYANIDE WITH AUROTHIOMALATE', JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 25, pp. 163 - 173, http://dx.doi.org/10.1016/0162-0134(85)80010-6

Lee E; Williams K; Day R; Graham G; Champion D, 1985, 'Stereoselective disposition of ibuprofen enantiomers in man.', British Journal of Clinical Pharmacology, vol. 19, pp. 669 - 674, http://dx.doi.org/10.1111/j.1365-2125.1985.tb02694.x

Barratt RL; Graham GG; Torda TA, 1984, 'Kinetics of thiopentone in relation to the site of sampling', British Journal of Anaesthesia, vol. 56, pp. 1385 - 1392, http://dx.doi.org/10.1093/bja/56.12.1385

Graham GG; Day RO; Champion GD; Lee E; Newton K, 1984, 'Aspects of the clinical pharmacology of non-steroidal anti- inflammatory drugs', Clinics in Rheumatic Diseases, vol. 10, pp. 229 - 249

Graham GG; Haavisto TM; Jones HM; Champion GD, 1984, 'The effect of cyanide on the uptake of gold by red blood cells', Biochemical Pharmacology, vol. 33, pp. 1257 - 1262, http://dx.doi.org/10.1016/0006-2952(84)90178-3

Barrett R; Graham GG; Torda TA, 1984, 'The influence of sampling site upon the distribution phase kinetics of thiopentone', Anaesthesia and Intensive Care, vol. 12, pp. 5 - 9, http://dx.doi.org/10.1177/0310057x8401200101

Lee EJD; Williams KM; Graham GG; Day RO; Champion GD, 1984, 'Liquid chromatographic determination and plasma concentration profile of optical isomers of ibuprofen in humans', Journal of Pharmaceutical Sciences, vol. 73, pp. 1542 - 1544, http://dx.doi.org/10.1002/jps.2600731112

Day RO; Graham GG; Champion GD; Lee E, 1984, 'Anti-rheumatic drug interactions', Clinics in Rheumatic Diseases, vol. 10, pp. 251 - 275

GRAHAM GG; HAAVISTO TM; JONES HM; CHAMPION GD, 1984, 'THE EFFECT OF CYANIDE ON THE UPTAKE OF GOLD BY RED-BLOOD-CELLS', BIOCHEMICAL PHARMACOLOGY, vol. 33, pp. 1257 - 1262, http://dx.doi.org/10.1016/0006-2952(84)90178-3

Günsberg M; Bochner F; Graham G; Imhoff D; Parsons G; Cham B, 1984, 'Disposition of and clinical response to salicylates in patients with rheumatoid disease', Clinical Pharmacology and Therapeutics, vol. 35, pp. 585 - 593, http://dx.doi.org/10.1038/clpt.1984.81

GRAHAM GG; JONES HM; MACPHERSON TM; CHAMPION GD, 1983, 'STUDIES ON THE MECHANISM BY WHICH SMOKING INCREASES THE UPTAKE OF GOLD BY RED-BLOOD-CELLS', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 10, pp. 674 - 675, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

DAY RO; HARRIS G; BROWN M; GRAHAM G, 1983, 'ASPIRIN GLUCOCORTICOSTEROID INTERACTION IN MAN', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 10, pp. 717 - 717, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Graham G, 1983, 'Aspirin in rheumatoid arthritis and osteo-arthritis', Australian Journal of Pharmacy, vol. 64, pp. 837 - 839

Graham GG; Haavisto TM; McNaught PJ; Browne CD; Champion GD, 1982, 'The effect of smoking on the distribution of gold in blood', Journal of Rheumatology, vol. 9, pp. 527 - 531, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PG29000007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

CHAMPION GD; BIERI D; BROWNE CD; DAY RO; GRAHAM GG; HAAVISTO TM; SAMBROOK PN; VALLANCE JB, 1982, 'AURANOFIN IN RHEUMATOID-ARTHRITIS', JOURNAL OF RHEUMATOLOGY, vol. 9, pp. 137 - 145, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN15300021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

HARRIS G; CAIRNS D; BIERI D; CHAMPION D; DAY R; GRAHAM G, 1982, 'RESPONSE OF RHEUMATOID-ARTHRITIS TO SLOWLY ACTING ANTI-RHEUMATIC DRUGS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, vol. 12, pp. 561 - 561, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Day RO; Sambrook P; Champion GD; Graham GG, 1982, 'Antimalarials in rheumatic diseases', Australian and New Zealand Journal of Medicine, vol. 12, pp. 645 - 649, http://dx.doi.org/10.1111/j.1445-5994.1982.tb02658.x

IMHOFF D; BOCHNER F; GUNSBERG M; GRAHAM G; PARSONS G; CHAM B; BYRNE G, 1982, 'SALICYLATES IN RHEUMATOID DISEASE', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 9, pp. 460 - 461, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PJ26400123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Graham GG, 1982, 'Noninvasive chemical methods of estimating pharmacokinetic parameters', Pharmacology and Therapeutics, vol. 18, pp. 333 - 349, http://dx.doi.org/10.1016/0163-7258(82)90036-5

Tung C; Graham GG; Wade DN; Williams KM, 1982, 'The pharmacokinetics of chlorbutol in man', Biopharmaceutics & Drug Disposition, vol. 3, pp. 371 - 378, http://dx.doi.org/10.1002/bdd.2510030410

Bochner F; Graham GG; Cham BE; Imhoff DM; Haavisto TM, 1981, 'Salicylate metabolite kinetics after several salicylates', Clinical Pharmacology and Therapeutics, vol. 30, pp. 266 - 275, http://dx.doi.org/10.1038/clpt.1981.158

Portek I; Graham G; Fleming A, 1981, 'Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability', Medical Journal of Australia, vol. 2, pp. 39 - 40, http://dx.doi.org/10.5694/j.1326-5377.1981.tb132057.x

Haavisto TM; Champion GD; Graham GG; McNaught PJ, 1981, 'The influence of smoking on the distribution of gold in blood', Clinical and Experimental Pharmacology and Physiology, vol. 8, pp. 674 - 675, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1981NC42000135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McNaught PJ; Champion GD; Graham GG; Haavisto TM, 1981, 'The influence of smoking on the distribution of gold sodium thiomalate', Australian and New Zealand Journal of Medicine, vol. 11, pp. 723 - 724, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1981MS36500062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Graham GG; Champion GD; Haavisto TM; McNaught PJ, 1981, 'Gold binding to red blood cells.', Annals of the rheumatic diseases, vol. 40, pp. 210, http://dx.doi.org/10.1136/ard.40.2.210-a

Liddle C; Graham GG; Christopher RK; Bhuwapathanapun S; Duffield AM, 1981, 'Identification of new urinary metabolites in man of quinine using methane chemical ionization gas chromatography-mass spectrometry', Xenobiotica, vol. 11, pp. 81 - 87, http://dx.doi.org/10.3109/00498258109045277

Tung C; Graham GG; Wade DN; Williams KM, 1980, 'The pharmacokinetics of chlorbutol', Clinical and Experimental Pharmacology and Physiology, vol. 7, pp. 672, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1980KV12600062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Graham GG; Chinwah P; Kennedy M; Wade DN, 1980, 'Monitoring plasma concentrations of drugs', Medical Journal of Australia, vol. 2, pp. 124 - 130, http://dx.doi.org/10.5694/j.1326-5377.1980.tb76940.x

LIDDLE C; BHUWAPATHANAPUN S; CHRISTOPHER RK; GRAHAM GG; DUFFIELD AM, 1979, 'IDENTIFICATION BY GC/MS OF SOME QUININE METABOLITES IN URINE', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 6, pp. 171 - 171, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1979GL67900013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

RAY JE; WADE DN; GRAHAM GG; DAY RO, 1979, 'Pharmacokinetics of Carprofen in Plasma and Synovial Fluid', The Journal of Clinical Pharmacology, vol. 19, pp. 635 - 643, http://dx.doi.org/10.1002/j.1552-4604.1979.tb01626.x

Graham G; Champion GD; Day RO, 1979, 'The pharmacokinetics of salicyclate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, vol. 6, pp. 194

Graham GG; Kennedy M, 1979, 'Clinical pharmacokinetics', Medical Journal of Australia, vol. 1, pp. 388 - 385, http://dx.doi.org/10.5694/j.1326-5377.1979.tb126969.x

Graham GG; Kennedy M, 1979, 'Drug metabolism', Medical Journal of Australia, vol. 1, pp. 441 - 444, http://dx.doi.org/10.5694/j.1326-5377.1979.tb127022.x

Borody T; Chinwah PM; Graham GG; Wade DN; Williams KM, 1979, 'Chlorbutol toxicity and dependence', Medical Journal of Australia, vol. 1, pp. 288, http://dx.doi.org/10.5694/j.1326-5377.1979.tb112109.x

Graham G; Carroll P; Haavisto TM, 1979, 'Comparative pharmacokinetics of quinine and quinidine', Clinical and Experimental Pharmacology and Physiology, vol. 6, pp. 647, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1979HV68000022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ray JE; Wade DN; Graham GG, 1979, 'Absorption and metabolism of [¹⁴C]carprofen in man', Clinical and Experimental Pharmacology and Physiology, vol. 6, pp. 175 - 176

Champion GD; Day RO; Paull PD; Graham GG; Owen MS; Haski AL; Hills L, 1978, 'Clinical Pharmacology and Efficacy of Benorylate in Patients with Rheumatoid Arthritis', Australian and New Zealand Journal of Medicine, vol. 8, pp. 22 - 28, http://dx.doi.org/10.1111/j.1445-5994.1978.tb02398.x

Graham GG; Kennedy M, 1978, 'Drug absorption and bioavailability', Medical Journal of Australia, vol. 2, pp. 143 - 147, http://dx.doi.org/10.5694/j.1326-5377.1978.tb131421.x

Lau A; Graham G; Birkett DJ; Myers SP, 1978, 'Comparative pharmacokinetics of quinine and quinidine in man', Clinical and Experimental Pharmacology and Physiology, vol. 5, pp. 247

Paull P; Wade DN; Graham GG, 1978, 'The absorption of benorylate in an in vitro everted rat small intestine model', Clinical and Experimental Pharmacology and Physiology, vol. 5, pp. 282 - 283

Howe GB; Bieri D; Champion GD; Graham G; Haski AL; HILLS LJ; Spencer DG; Stitt FW, 1978, 'CLINICAL TRIAL OF NAPROXEN IN RHEUMATOID ARTHRITIS', Australian and New Zealand Journal of Medicine, vol. 8, pp. 181 - 181, http://dx.doi.org/10.1111/j.1445-5994.1978.tb04843.x

Champion GD; Graham GG, 1978, 'Pharmacokinetics of Non‐Steroidal Anti‐Inflammatory Agents', Australian and New Zealand Journal of Medicine, vol. 8, pp. 94 - 100, http://dx.doi.org/10.1111/j.1445-5994.1978.tb04794.x

Graham GG; Champion GD; Day RO; Kaski AL; Hills LG; Paull PD, 1977, 'Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic response.', Agents and Actions Supplements, pp. 37 - 42

Champion GD; Day RO; Fagan N, 1977, 'Single dose comparison of analgesic action of acetylsalicylate and sodium salicylate in rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, vol. 4, pp. 213

Graham G; Champion GD; Day RO; Paull PD, 1977, 'The pharmacokinetics of salicylate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, vol. 4, pp. 214

Birkett DJ; Graham GG; Chinwah PM; Wade DN; Hickie JB, 1977, 'Multiple drug interactions with phenytoin', Medical Journal of Australia, vol. 2, pp. 467 - 468, http://dx.doi.org/10.5694/j.1326-5377.1977.tb117733.x

Graham GG; Champion GD; Day RO; Paull PD, 1977, 'Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, vol. 22, pp. 410 - 420, http://dx.doi.org/10.1002/cpt1977224410

Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG, 1977, 'The Effects of Enteric Coating of Aspirin Tablets on Occult Gastrointestinal Blood Loss', Australian and New Zealand Journal of Medicine, vol. 7, pp. 600 - 604, http://dx.doi.org/10.1111/j.1445-5994.1977.tb02315.x

Graham GG; Champion GD, 1976, 'Correlation of plateau serum salicylate with rate of salicylate metabolism', Clinical Pharmacology and Therapeutics, vol. 20, pp. 120 - 122

Paull P; Day R; Graham G; Champion D, 1976, 'Single dose evaluation of a new enteric coated aspirin preparation', Medical Journal of Australia, vol. 1, pp. 617 - 619, http://dx.doi.org/10.5694/j.1326-5377.1976.tb140908.x

Day RO; Paull PD; Champion GD; Graham GG, 1976, 'Evaluation of an Enteric Coated Aspirin Preparation', Australian and New Zealand Journal of Medicine, vol. 6, pp. 45 - 50, http://dx.doi.org/10.1111/j.1445-5994.1976.tb03290.x

Mearrick PT; Graham GG; Wade DN, 1975, 'The role of the liver in the clearance of l-dopa from plasma', Journal of Pharmacokinetics and Biopharmaceutics, vol. 3, pp. 13 - 23, http://dx.doi.org/10.1007/BF01066592

Paull PD; Day RO; Graham GG; Champion GD, 1975, 'Bioavailability of enteric coated aspirin', Clinical and Experimental Pharmacology and Physiology, vol. 2, pp. 442

Pond SM; Graham GG; Wade DN, 1975, 'A critical evaluation of drug interactions in man: the effect of tricyclic antidepressants on dicoumarol elimination', Clinical and Experimental Pharmacology and Physiology, vol. 2, pp. 443 - 444

Pond SM; Graham GG; Birkett DJ; Wade DN, 1975, 'Effects of tricyclic antidepressants on drug metabolism', Clinical Pharmacology and Therapeutics, vol. 18, pp. 191 - 199, http://dx.doi.org/10.1002/cpt1975182191

Graham G; Mearrick PT; Wade DN, 1975, 'The role of the liver in the clearance of levodopa', Clinical and Experimental Pharmacology and Physiology, vol. 2, pp. 414 - 415

Mearrick PT; Graham GG; Wade DN; Morris JL, 1975, 'The clearance of levodopa from plasma', Clinical and Experimental Pharmacology and Physiology, vol. 2, pp. 415 - 416

Pond SM; Graham GG; Wade DN; Sudlow G, 1975, 'The Effects of Allopurinol and Clofibrate on the Elimination of Coumarin Anticoagulants in Man', Australian and New Zealand Journal of Medicine, vol. 5, pp. 324 - 328, http://dx.doi.org/10.1111/j.1445-5994.1975.tb03266.x

Graham G; Bolt AG, 1974, 'Half-life of diphenylpyraline in man', Journal of Pharmacokinetics and Biopharmaceutics, vol. 2, pp. 191 - 195, http://dx.doi.org/10.1007/BF01059761

Bolt AG; Graham G; Wilson P, 1974, 'Stereoselective demethylation of the enantiomers of nefopam, an experimental antidepressant and skeletal muscle relaxant', Xenobiotica, vol. 4, pp. 355 - 363, http://dx.doi.org/10.3109/00498257409052111

Rowland M; Benet L; Graham G, 1973, 'Clearance concepts in pharmacokinetics', Journal of Pharmacokinetics and Biopharmaceutics, vol. 1, pp. 123 - 136, http://dx.doi.org/10.1007/BF01059626

Graham G; Sleigh MJ; Bolt AG, 1972, 'Measurements of monoamine oxidase activity using [14C]tryptamine', Journal of Pharmacy and Pharmacology, vol. 24, pp. 909 - 911, http://dx.doi.org/10.1111/j.2042-7158.1972.tb08914.x

Graham G; Rowland M, 1972, 'Application of salivary salicylate data to biopharmaceutical studies of salicylates', J. Pharm. Sci., vol. 61, pp. 1219 - 1222, http://dx.doi.org/10.1002/jps.2600610810

Quane PA; Graham GG; Zeigler J, 1997, 'Effects of benzydamine on the oxidative burst of neutrophils and on lactoperoxidase', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, presented at Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, 30 November 1997 - 01 December 1997

Daly EB; Graham GG; Torda TA, 1997, 'Pharmacokinetic analysis of time course of atracurium', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, presented at Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, 30 November 1997 - 01 December 1997

Graham GG; Mortlet N; Gatus BJ; Maclean AL; Salonikas C; Naidoo D; Goldberg I, 1997, 'The pharmacokinetics of ciproflacin in the human eye: a population pharmacokinetic analysis', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, presented at Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, 30 November 1997 - 01 December 1997

Ziegler JB; Graham GG; Day RO; Williams KM; Milligan MK, 1997, 'THERAPEUTIC CONSIDERATIONS FROM PHARMACOKINETICS AND METABOLISM: IBUPROFEN AND PARACETAMOL.', in Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht, presented at Safety and Efficacy of non-prescription analgesics and NSAIDS, San Francisco, California USA, 17 March 1997 -

Bolisetty S; Gupta J; Graham GG; Salonikas C; Naidoo D, 1997, 'Regular vitamin K supplementation to lactating mothers - does it help?', in Annual Congress of the Australian and New Zealand Perinatal Society, Annual Congress of the Australian and New Zealand Perinatal Society, presented at Annual Congress of the Australian and New Zealand Perinatal Society

Graham GG; Ziegler JB; Champion GD, 1993, 'Medicinal chemistry of gold', in Agents and Actions, Switzerland, pp. 209 - 217, Switzerland, https://www.ncbi.nlm.nih.gov/pubmed/8103963

RUDKOWSKI R; CHAMPION GD; GRAHAM GG; ZIEGLER JB, 1986, 'THE EFFECTS OF AUROCYANIDE, AUROTHIOMALATE AND AURANOFIN ON THE OXIDATIVE BURST OF POLYMORPHONUCLEAR LEUKOCYTES', in AUSTRALIAN PAEDIATRIC JOURNAL, BLACKWELL SCIENCE, pp. 337 - 338, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986H083600045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

CHAMPION GD; DAY RO; PAULL PD; GRAHAM GG; OWEN MS; HASKI AL, 1975, 'CLINICAL PHARMACOLOGY AND EFFICACY OF BENORYLATE IN PATIENTS WITH RHEUMATOID-ARTHRITIS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, ADIS PRESS AUSTRALASIA P/L, Vol. 5, pp. 501 - 501, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1975AU07300093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1